Clinical Trial Update: A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 study evaluating a two-week ketogenic diet in combination with letrozole to modulate PI3K signaling in estrogen receptor-positive breast cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Estrogen Receptor-positive Breast Cancer | EARLY_Phase 1 | Status: COMPLETED